These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 11041228

  • 1. Circulating sex hormones and endometrial stromelysin-1 (matrix metalloproteinase-3) at the start of bleeding episodes in levonorgestrel-implant users.
    Marbaix E, Vekemans M, Galant C, Rigot V, Lemoine P, Dubois D, Picquet C, Henriet P, Twagirayezu P, Sufi S, Eeckhout Y, Courtoy PJ.
    Hum Reprod; 2000 Aug; 15 Suppl 3():120-34. PubMed ID: 11041228
    [Abstract] [Full Text] [Related]

  • 2. Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users.
    Darney PD, Taylor RN, Klaisle C, Bottles K, Zaloudek C.
    Contraception; 1996 Feb; 53(2):97-100. PubMed ID: 8838486
    [Abstract] [Full Text] [Related]

  • 3. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W, Reinprayoon D, Pruksananonda K, Niruttisard S, Triratanachat S, Leepipatpaiboon S, Wannakrairot P.
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [Abstract] [Full Text] [Related]

  • 4. Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception.
    Subakir SB, Hadisaputra W, Siregar B, Irawati D, Santoso DI, Cornain S, Affandi B.
    Hum Reprod; 1995 Oct; 10(10):2579-83. PubMed ID: 8567774
    [Abstract] [Full Text] [Related]

  • 5. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA, Wang S, Rogers P, Vince G, Affandi B.
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [Abstract] [Full Text] [Related]

  • 6. Endometrial angiogenic response in Norplant users.
    Subakir SB, Hadisaputra W, Handoyo AE, Affandi B.
    Hum Reprod; 1996 Oct; 11 Suppl 2():51-5. PubMed ID: 8982746
    [Abstract] [Full Text] [Related]

  • 7. Matrix metalloproteinase-1 and -3 and mast cells are present in the endometrium of women using progestin-only contraceptives.
    Vincent AJ, Zhang J, Ostor A, Rogers PA, Affandi B, Kovacs G, Salamonsen LA.
    Hum Reprod; 2000 Jan; 15(1):123-30. PubMed ID: 10611200
    [Abstract] [Full Text] [Related]

  • 8. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant).
    Marsh MM, Butt AR, Riley SC, Rogers PA, Susil B, Affandi B, Findlay JK, Salamonsen LA.
    Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775
    [Abstract] [Full Text] [Related]

  • 9. Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding.
    Chegini N, Rhoton-Vlasak A, Williams RS.
    Fertil Steril; 2003 Sep; 80(3):564-70. PubMed ID: 12969699
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use.
    Au CL, Affandi B, Rogers PA.
    Contraception; 1994 Nov; 50(5):477-89. PubMed ID: 7859456
    [Abstract] [Full Text] [Related]

  • 11. Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant implants.
    Faúndes A, Alvarez F, Brache V, Cochón L.
    Hum Reprod; 1998 Jan; 13(1):188-91. PubMed ID: 9512255
    [Abstract] [Full Text] [Related]

  • 12. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception.
    Runic R, Schatz F, Krey L, Demopoulos R, Thung S, Wan L, Lockwood CJ.
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1983-8. PubMed ID: 9177417
    [Abstract] [Full Text] [Related]

  • 13. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
    Witjaksono J, Lau TM, Affandi B, Rogers PA.
    Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
    [Abstract] [Full Text] [Related]

  • 14. Bcl-2, Fas and caspase 3 expression in endometrium from levonorgestrel implant users with and without breakthrough bleeding.
    Rogers PA, Lederman F, Plunkett D, Affandi B.
    Hum Reprod; 2000 Aug; 15 Suppl 3():152-61. PubMed ID: 11041231
    [Abstract] [Full Text] [Related]

  • 15. Endometrial vasculature in Norplant users.
    Rogers PA.
    Hum Reprod; 1996 Oct; 11 Suppl 2():45-50. PubMed ID: 8982745
    [Abstract] [Full Text] [Related]

  • 16. Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9 (gelatinase B).
    Vincent AJ, Malakooti N, Zhang J, Rogers PA, Affandi B, Salamonsen LA.
    Hum Reprod; 1999 Mar; 14(3):807-15. PubMed ID: 10221718
    [Abstract] [Full Text] [Related]

  • 17. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
    Lau TM, Witjaksono J, Affandi B, Rogers PA.
    Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
    [Abstract] [Full Text] [Related]

  • 18. Endometrial vasculature in Norplant users: preliminary results from a hysteroscopic study.
    Hickey M, Fraser I, Dwarte D, Graham S.
    Hum Reprod; 1996 Oct; 11 Suppl 2():35-44. PubMed ID: 8982744
    [Abstract] [Full Text] [Related]

  • 19. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding.
    Hickey M, Fraser IS.
    Hum Reprod; 2002 Sep; 17(9):2428-34. PubMed ID: 12202436
    [Abstract] [Full Text] [Related]

  • 20. Correlation between endometrial histology, microvascular density and calibre, matrix metalloproteinase-3 and bleeding pattern in women using a levonorgestrel-releasing intrauterine system.
    Oliveira-Ribeiro M, Petta CA, De Angelo Andrade LA, Bahamondes L, Hidalgo MM.
    Hum Reprod; 2004 Aug; 19(8):1778-84. PubMed ID: 15192067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.